# Clinical Trial of Safety and Efficacy of Various Dosage Schedules for Dietressa Drug in Treatment of Obese Patients

> **NCT01535014** · PHASE3 · COMPLETED · sponsor: **Materia Medica Holding** · enrollment: 493 (actual)

## Conditions studied

- Obesity

## Interventions

- **DRUG:** Dietressa
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT01535014
- **Lead sponsor:** Materia Medica Holding
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-12-12
- **Primary completion:** 2013-06
- **Final completion:** 2013-06
- **Target enrollment:** 493 (ACTUAL)
- **Last updated:** 2018-11-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01535014

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01535014, "Clinical Trial of Safety and Efficacy of Various Dosage Schedules for Dietressa Drug in Treatment of Obese Patients". Retrieved via AI Analytics 2026-05-24 from https://api.ai-analytics.org/clinical/NCT01535014. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*